Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

According to the National Family Health Survey-5 (2019–21), 24% of Indian women and 23% of Indian men are either overweight ...

Health news includes a cyberattack affecting patient care in London, Walgreens' financial success amid strategic changes, ...

Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...

Escape Fitness has unveiled its Glute Station attachment, which has been designed to meet the rising consumer demand for glute-focused training. The Escape Fitness Glute Station provides a lifting ...

The quest for weight loss has taken a dramatic turn. A wave of new-age solutions, from once-weekly injectables like Wegovy ...

Britain's vehicle manufacturing sector has plunged to depths not witnessed since 1949 in a major wake-up call for the vital industry. Car and commercial vehicle production in May 2025 plummeted 32.8 ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

India’s health regulator has approved Eli Lilly’s pre-filled pen version of Mounjaro, expanding its availability across six ...

Eli Lilly announced that its breakthrough drug, Mounjaro (tirzepatide), has received marketing authorization from India’s ...

Apollo HealthCo clocked a revenue of ₹9,093 crore in FY25, growing 16% year-on-year. The platform delivered three successive ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...